booster dose giving good results against omicron, data to be made public soon: dr krishna ella
Published 2 years ago • 527 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
25:33
bharat biotech’s dr. krishna ella shares his view: is vaccine advisable for kids? | frankly speaking
-
6:00
do i need a covid booster? will it protect against the omicron variant?
-
3:47
ask dr. agus: new covid boosters to target omicron
-
8:55
india hits 100 cr vaccine milestone, et now speaks to dr. krishna ella(bharat biotech chairman)
-
0:33
doctor mike gets covid vaccines & booster
-
4:08
covid-19: more seeking non-mrna vaccines for booster jabs | the big story
-
21:14
leaders of tomorrow | season 10 | bharat biotech | dr. krishna ella
-
3:40
video: do covid-19 vaccine, booster still offer enough protection for elderly patients?
-
0:49
covid-19 booster shot for immunocompromised? #shorts
-
1:20:35
mystery of booster dose - do you need covid-19 vaccine booster?
-
2:24
pfizer says early data shows covid booster appears to offer omicron protection
-
9:11
dr krishna ella, chairman bharat biotech exclusive | covid news | covid vaccine latest | cnn news18
-
3:11
dr krishna ella, cmd bharat biotech speaks on covaxin to india today
-
6:31
6 of our other vaccines have already been approved by who: bharat biotech
-
6:34
dr krishna ella speaks on the challenges of developing covid-19 vaccine & human trials
-
2:20
dr. david agus on the growing confusion about covid-19 vaccine booster shots
-
5:20
bharat biotech founder dr krishna ella: i am not a vaccine nationalist but scientist| covaxin row
-
4:41
india's mega mission booster from tomorrow | covid vaccination drive | all you need to know
-
21:46
moderna booster more effective for seniors previously jabbed with pfizer vaccine | the big story
-
2:33
israel approves 2nd booster dose for elderly, health workers against omicron | english news | wion
-
1:28
moderna booster gives higher antibody response among elderly vaccinated with pfizer: ncid study
-
12:58
doctor on covid surges and need for data on natural immunity